Showing results (1281-1290 of 15,138) with videos related to

Sort By:
Pageof 1,514
BMC Infectious Diseases|July 5, 2018
Tuberculous pneumonia-induced severe ARDS complicated with DIC in a female child: a case of successful treatmentDong Tien Ngo, Phuc Huu Phan, Shoji Kawachi, et al.
BMC Infectious Diseases|July 5, 2018
Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatmentLubiao Chen, Dujing Bao, Lin Gu, et al.
BMC Infectious Diseases|July 6, 2018
Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapyRokeya Sultana Rekha, Akhirunnesa Mily, Tajnin Sultana, et al.
BMC Infectious Diseases|July 7, 2018
The relation of secondary sex ratio and miscarriage history with Toxoplasma gondii infectionSaeedeh Shojaee, Aref Teimouri, Hossein Keshavarz, et al.
BMC Infectious Diseases|July 18, 2018
Preliminary results of official influenza and acute respiratory infection surveillance in two towns of Burkina Faso, 2013-2015Tani Sagna, Abdoul Kader Ilboudo, Carine Wandaogo, et al.
BMC Infectious Diseases|June 9, 2018
Recurrence of tuberculosis in a low-incidence setting: a retrospective cross-sectional study augmented by whole genome sequencingLaila Parvaresh, Taryn Crighton, Elena Martinez, et al.
BMC Infectious Diseases|June 9, 2018
Tuberculosis case finding using population-based disease surveillance platforms in urban and rural KenyaGodfrey Bigogo, Kevin Cain, Diana Nyole, et al.
BMC Infectious Diseases|July 13, 2018
Primary invasive laryngeal mycosis in an immunocompetent patient: a case report and clinico-epidemiological updateSupram Hosuru Subramanya, Joseph Jillwin, Shivaprakash Mandya Rudramurthy, et al.
BMC Infectious Diseases|June 3, 2018
Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infectionsYoung Ah Kim, Kyungwon Lee, Jae Eun Chung
BMC Infectious Diseases|June 3, 2018
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in EuropeLuna Colagrossi, Lucas E Hermans, Romina Salpini, et al.
Pageof 1,514